A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
University of Washington
Massachusetts General Hospital
University of Ulm
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
Gilead Sciences
H. Lee Moffitt Cancer Center and Research Institute
University of Washington
University of Washington
Incyte Corporation
Masonic Cancer Center, University of Minnesota
University of Maryland, Baltimore
City of Hope Medical Center
University of Miami
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
MEI Pharma, Inc.
AstraZeneca
BeiGene
BeiGene
Academic and Community Cancer Research United
University of Colorado, Denver
City of Hope Medical Center
City of Hope Medical Center
Mayo Clinic
University of Nebraska
University of Nebraska
Eastern Cooperative Oncology Group
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
International Extranodal Lymphoma Study Group (IELSG)
Fred Hutchinson Cancer Center
Mayo Clinic
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Washington
University of Arizona
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic